Andrew G. Bosanquet

Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy

Isrid Sturm, Andrew G. Bosanquet, Sandra Hermann et al. · Cell Death and Differentiation · 2003 · 143 citations · Full text

B-cll Occurs, Health Sciences, Medicine +9

High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities

Patrick Thornton, Estella Matutes, Andrew G. Bosanquet et al. · Annals of Hematology · 2003 · 102 citations

Oncology, Pathology, High Dose Methylprednisolone +7

Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma

Andrew G. Bosanquet, Edward D. Gilby · European Journal of Cancer and Clinical Oncology · 1982 · 85 citations

Hematological Malignancy, Oncology, Medicine +8

Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay

Andrew G. Bosanquet · The Lancet · 1991 · 82 citations

Hematological Malignancy, Oncology, Medicine +11

Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in-vitro chemosensitivity of haematological malignancies

Martin C. Bird, Andrew G. Bosanquet, Susan Forskitt et al. · Leukemia Research · 1986 · 54 citations

Hematological Malignancy, Health Sciences, Medicine +11